Dr. med. Valentina Bianchi Galdi

Kontakt

Esperto FTGS in consulenza e trattamento del tabagismo
Medical Examiner of Divers (MED), membro SUHMS
Medicina Generale, membro FMH 


Berufserfahrung

seit 2020 Titolare proprio Studio Medico, Medicina Generale e Tabaccologia
 
seit 2017 Collaboratrice Scientifica presso l’EOC – Direzione Generale, Area di Supporto 
Capo Progetto pilota “ORL: verso un ospedale senza fumo” (01.06.18-31.12.2019)
2014-2017 Collaboratrice Scientifica presso l’EOC – EOQUAL (Servizio Qualità e Sicurezza pazienti), Ospedale Regionale di Lugano
Medico Scientifico UCEP (Unità Cantonale Epato-Bilio-Pancreatica), EOC
2011-2013 Collaboratrice Scientifica e Coordinatrice di Progetto, presso il Registro Cantonale dei Tumori (Direttore: Dr. med. A. Bordoni), Istituto Cantonale di Patologia, Locarno.
Progetto: “Indicators of Quality of Cancer Care (QC3) in Southern Switzerland”.
Lo studio è stato sponsorizzato da: Krebsforschung Schweiz, grant no. KFS-02668-08-2010; ABREOC (Advisory Board Ente Ospedaliero Bellinzona), grant no. ABREOC 10/2010, Swiss Academy of Medical Sciences, grant no. KZS 3/11; Zonta Club Locarno.
2010 EOC - Ospedale Regionale Bellinzona e Valli, sede di Faido, Dipartimento di Medicina Interna (Resp.: Dr. med. A. Valenti)
2004-2009 EOC - IOSI (Istituto Oncologico della Svizzera Italiana, Direttore: Prof. Dr. med. M. Ghielmini), Bellinzona.
2002-2003 EOC - Ospedale Regionale di Lugano, Dipartimento di Medicina Interna (Direttore: Prof. Dr. med. A. Cerny), Lugano.
2001-2002 Ricercatrice presso l’Inselspital Bern, Dipartimento di Ematologia, Laboratorio di Ematologia Sperimentale (Direttore: Prof. Dr. med. B. Lämmle), Berna. Progetti svolti:
  • Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies
  • Von Willebrand factor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP)
  • Von Willebrand factor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock
Gli studi sono stati in parte sponsorizzati da un grant della “Fondazione per la ricerca sulla trasfusione e sui trapianti”, Lugano.
1999-2000 Ricercatrice presso l’ETH-Zentrum-Swiss Federal Institute of Technology, Dipartimento di Biochimica (Responsabile: H. Lutz, Ph.D.), Zurigo.
Progetto: “Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level”.
Lo studio è stato sponsorizzato da: KTI grants no. 3189.1 and 3772.1 of ZLB Central Laboratory, Blood Transfusion Services of the Swiss Red Cross, Bern, and by the Swiss Government.
1998-1999 Medico Consulente presso il Laboratorio di Analisi “Beccaria” (Direttore: Dr. biol. B. Calegari), Varese (I)
1997-1998 Ricercatrice presso il Dipartimento di BioTecnologie (DIBIT), Unità di Immunochimica (Responsabile: Dr. med. Paolo Dellabona e Giulia Casorati, Ph.D.), Ospedale San Raffaele, Milano.
 Progetto: “Characterization of new chemokines mPBP-like, mPF4-like e hIP10-like in tumoral angiogenesis”. 
      
1995-1997 Medico Specializzando in Chirurgia Generale ad indirizzo Oncologico presso la Scuola di Specializzazione in Chirurgia Generale dell’Università di Pavia, Sede di Varese (I) (Direttore: Prof. Dr. med. R. Dionigi) e presso il Laboratorio di Chirurgia Sperimentale dell’Università di Pavia, Sede di Varese (I) (Direttore: Prof. Dr. med. R. Dionigi). Progetti svolti:
  • In vitro effect of intravenous immunoglobulins (IVIG) on the opsonophagocytic function of neutrophils from severely septic patients
  • Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins
  • Immediate postoperative enteral nutrition, sequential treatment of infected pancreatic necrosis with zipper abdominal re-explorations, open abdomen and continuous lavage
1994 Visiting Student (European Society for Organ Transplantation, E.S.O.T. Fellowship), Ludwig-Maximilians-Universität, Klinikum Großhadern, Institute of Surgical Research (Director: Prof. Dr. med. Dr. med. vet. C. Hammer).
1992-1995 Candidato Medico ed Internato presso il Dipartimento di Chirurgia Generale dell’Università di Pavia, Sede di Varese (I) (Direttore: Prof. Dr. med. R. Dionigi) e presso il Laboratorio di Chirurgia Sperimentale dell’Università di Pavia, Sede di Varese (I) (Direttore: Prof. Dr. med. R. Dionigi).

Ausbildung

2021 Certificato “Covid-19 and Tobacco Use”. John Hopkins Bloomberg School of Public Health, Institute for Global Tobacco Control, Baltimore, MD (USA) 
2021 Certificato II Livello “Il trattamento individuale del tabagismo”. Società Italiana di Tabaccologia Nsmt, National School Of Medical Tobaccology. 
2021 Certificato I Livello“Il Counseling motivazionale breve per il tabagismo”. Società Italiana di tabaccologia Nsmt, National School Of Medical Tobaccology 
2020 Certificate "Motivational interviewing in health care", Psychwire (by Dr. Stephen Rollnick and Dr. William Miller)
2019 Diploma FTGS/GNTH “expertin für nikotinberatung & tabakentwöhnung” forum tabakprävention und behandlung der tabakabhängigkeit in gesundheitsinstitutionen schweiz/the global network for tobacco free healthcare services, Zürich (ch)
2019 Diploma “Expertin Für Nikotinberatung & Tabakentwöhnung Ftgs/Gnth” Forum Tabakprävention Und Behandlung Der Tabakabhängigkeit In Gesundheitsinstitutionen Schweiz/The Global Network For Tobacco Free Healthcare Services, Zürich (CH) 
2019 ENSP Certificate “The European Network For Smoking Prevention’s Accredited Curriculum On Tobacco Treatment”. European Network For Smoking And Tobacco Prevention (ENSP) And European Accreditation Council For Continuing Medical Education (EACCME) 
2019 Erasmus + Programme Of The European Union Certificate “Smoking Cessation Advice: Healthcare Professional Training”. In coll. con L’università di Birmingham (UK), l’Università di Bordeaux (F), l’università di Milano (I), la Cooperativa de Ensiño Superior Politécnico E Universitario/Uics – Istituto Universitàrio Da Ciências Da Saùde di Gandra (P) e con l’Università di Santiago di Compostela (E) 
2019 “Learning from the Experts: A Course for Healthcare Professionals”. John Hopkins Bloomberg School Of Public Health, Institute For Global Tobacco Control, Baltimore, MD (USA) 
2019 “Global Tobacco Control: Learning from the Experts” Certificate. John Hopkins Bloomberg School of Public Health, Institute for Global Tobacco Control, Baltimore, MD (USA) 
2019 MCSCPD Certificate “Connecting with Patients for Tobacco Free Living”. Mayo Clinic School of Continuous Professional Development, Mayo Clinic College of Medicine and Science, Rochester, MN (USA)
2018 OTRU (Ontario Tobacco Research Unit) Certificate “Tobacco and Public Health: from Theory To Practice”. In coll. con L’università di Toronto, Dalla Lana School of Public Health, Canada 
2017 Corso “La consulenza stop tabacco – un nuovo paradigma nella gestione delle MNT”. Programma Nazionale per Smettere di Fumare, Ufficio Federale Della Salute Pubblica, Berna (CH) 
2015 Certificato CTU-EOC/Swissmedic Good Clinical Practice (GCP) for Investigators
2013 Titolo di perfezionamento medico generico, FMH
2010 Esame FMH-SGMO Oncologia medica
2010 Summer School in Public Health Policy, Economics and Management “Economic Evaluation and health Care Decision making”. Università della Svizzera Italiana, Facoltà di Scienze Economiche, Istituto di Microeconomia ed Economia Pubblica MecoP, Lugano (CH)
2009 Riconoscimento titolo federale di medico, MEBEKO
2004 Certificato SSMCP in cure palliative livello A
2003 Certificato SUHMS "Medical Examiner of divers"
2003 Certificazione "migliorare la comunicazione" per medici
2002 Corso Lega Polmonare Svizzera “Vivre sans tabac – conseil au fumeur”. Lugano (CH) 
2002 ACLS (Advanced Cardiac Life Support), CardioCentro Ticino, Lugano (CH)
1996 Abilitazione alla professione di Medico Chirurgo, Università di Pavia 
1995 Laurea in Medicina e Chirurgia (110/110 e Lode), Università di Pavia
Tesi: “Monitoraggio della fagocitosi dei leucociti polimorfonucleati nelle infezioni chirurgiche gravi trattate con IgG ad alte dosi”. Relatore: Prof. Dr. med. L. Dominioni

Mitgliedschaften

FMH
OMCT (Ordine dei Medici del Canton Ticino)
ASMAC (Associazione Svizzera dei Medici Assistenti e Capi Clinica)
FTGS (Forum Tabakprävention in Gesundheitsinstitutionen Schweiz), Board Member
GNTH (The Global Network for Tobacco Free Heathcare Services), Associate Member
ENSP (European Network for Smoking and Tobacco Prevention)
SITAB (Società Italiana di Tabaccologia)
ESMO (European Society of Medical Oncology)
SGAIM (Swiss Society of Internal Medicine)
SUHMS (Swiss Underwater and Hyperbaric Medical Society) 
SSMCP (Swiss Society of Palliative Care Medicine) 

Lehre

seit 2020 Responsabile progetto pilota “Sport snus-free” in coll. con FTHG (Federazione Ticinese Hockey su Ghiaccio), indirizzato alle Sezioni Giovanili
seit 2019 Referente FTGS (Forum Tabakprävention in Gesundheitsinstitutionen Schweiz) per il Canton Ticino
Membro Gruppo Strategico Nazionale “Strategie 2021 – 2028 Tabakprävention im Spitalsetting”
Membro Associato GNTH (The Global Network for Tobacco Free Healthcare Services)
Membro Senior GNTH  Gold Forum Jury (GNTH Gold Certificate)
Membro Board FTGS 
Referee per la rivista indicizzata “BMJ Open”
Membro del Programma d’azione cantonale (PAC) “Prevenzione alcol, tabacco e prodotti affini 2021-2024”
 
seit 2018 Docente nell’ambito del progetto dell’HC Lugano Sezione Giovanile “Educazione alla salute per giovani atleti” (programma di prevenzione su: fumo, alcool, droghe, alimentazione e doping)
2019 Responsabile del progetto e docente dei corsi per “Referente di Tabaccologia” rivolti al personale sanitario dell’ORL (EOC) nell’ambito del progetto pilota “ORL: verso un ospedale senza fumo”.
2009-2013 Membro del Comitato Editoriale della rivista a tiratura nazionale Palliative.ch
2002 Referee per la rivista indicizzata “Nephrology Dialysis and Transplantation”
2000-2001 Co-Supervisore della Tesi di Laurea in Medicina del Dr. med. Ph. Kessler intitolata “Evaluation of vWF-cp, vWF:Ag and vWF:RCof in severe sepsis and septic shock”. Università di Berna, Facoltà di Medicina, Dipartimento di Ematologia, Berna.
1999-2000 Lab-Tutor presso il corso di Biochimica per i Diplomi di Laurea in Farmacia e in Biochimica. ETH Zentrum, Dipartimento di Biochimica, Zurigo
1996-1997 Assistente presso il corso di Patologia Medica (Titolare: Dr. med. P.F. Interdonato) per il Bachelor in Scienze Infermieristiche dell’Università dell’Insubria, Varese (I)

Peer-reviewed journals:

Bianchi V, Spitale A, Ortelli L, Mazzucchelli L, Bordoni A and the QC3 CRC Working Group. Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open 2013;3:e002818. doi:10.1136/bmjopen-2013-002818.

Lutz HU, Stammler P, Bianchi V, Trueb RM, Hunziker T, Burger R, Jelezarova E, Spath PJ. Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004;103(2):465-472

Studt JD, Kremer Hovinga JA, Alberio L, Bianchi V, Lammle B. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory. Swiss Med Wkly 2003;133(23-24):325-332

Winkler A, Kremer Hovinga JA, Bianchi V, Studt JD, Lämmle B. Schistocytic anaemia, severe thrombocytopenia and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Hämostaseologie 2003;23(3):103-108

Lämmle B, Bianchi V, Alberio L, Furlan M. ADAMTS13 and thrombotic thrombocytopenic purpura: Letter to the Editor. Blood 2002;100:3839-3842

Bianchi V, Robles R, Alberio L, Furlan M and Lämmle B. Von Willebrand factor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP). Blood 2002;100:710-713

Dominioni L, Chiappa A, Bianchi V, Interdonato PF, Festi L, Carcano G, Benevento A, Dionigi R. Infected pancreatic necrosis complicated by multiple organ failure. Prospective study of sequential treatment with abdominal re-explorations, open abdomen and continuous closed lavage. Hepato-Gastroenterology 1997;44:968-974

Dominioni L, Bianchi V, Imperatori A, Minoia G, Dionigi R. High-dose intravenous IgG for treatment of severe surgical infections. Dig Surg 1996;13:430-434

Dominioni L, Chiappa A, Interdonato F, Festi L, Carcano G, Bianchi V, Frattini V, Peloni G, Dionigi R. Sequential treatment of infected pancreatic necrosis with zipper abdominal re-explorations, open abdomen and continuous lavage. Br J Surg 1996;83:863-864

Dominioni L, Chiappa A, Gavinelli M, Bianchi V, Dionigi R. Two-stage surgical treatment of rupture of the esophagus (Boerhaave’s syndrome) complicated by mediastinal abscess. J Em Surg 1995;18:68-72

Dominioni L, Berizzi F, Besozzi MC, Dozio E, Imperatori A, Bianchi V, Dionigi R. La nutrizione enterale postoperatoria immediata. Chir Italiana 1994; 46: 36-41

Gennari R, Dominioni L, Imperatori A, Bianchi V, Maroni P, Dionigi R. Alterations in lymphocyte subsets as prognosticators of postoperative infections. Eur J Surg 1994;161:493-499

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins. J R Coll Surg Edinb 1994;39:380

 

Abstracts pubblicati su peer-review journals:

Balzarotti R, Vitali G, Fournier I, Andres A, Cristaudi A, Toso C, Bianchi V, Rosso R, Morel P, Rubbia-Brandt L, Majno P. Evaluating the quality of liver resection for colorectal liver metastases using a standardised definition of the difficulty to obtain R0 surgical margins. BJS 2016;103(4):16 

Bianchi Galdi V, Franzetti-Pellanda A, Spitale A, Valli MC, Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A. Quality indicators in radiation therapy for rectal cancer. A population-based study in Southern Switzerland. Proceedings 2nd ESTRO Forum. Geneva, Switzerland, April 19-23, 2013. Radiotherapy & Oncology 2013;106:S162

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino: preliminary results in colorectal cancer. Proceedings 78th Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, November 8-10, 2012. Der Pathologe 2012;33:572

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. Proceedings 77th Annual Meeting of the Swiss Society of Pathology. Luzern, Switzerland, November 10-12, 2011. Der Pathologe 2011;32:536-7

Bianchi V, Celio D, Oudineche A, Mazzucchelli L, Saletti P, Rosso R. Bizarre cell leiomyoma of the duodenum: an entity of peculiar interest. Proceedings 96e Congrès Annuel de la Société Suisse de Chirurgie. Montreaux, Switzerland, June 10-12, 2009. Swiss Knife 2009; special edition: 68.60

Lutz HU, Stammler P, Bianchi V, Trüeb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ. Intravenously applied IgG stimulates complement attenuation in dermatomyositis at the amplifying C3 convertase level. Proceedings American Academy of Allergy, Asthma and Immunology (AAAAI) 60th Anniversary MeetingJ. Denver, Colorado, USA, March 7-12, 2003. J Allerg Clin Immunol 2003;111(1):S316

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for TTP. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for thrombotic thrombocytopenic purpura. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1): A6

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1):A6

 

Capitoli di libro:

Bianchi V. Riparazione delle ferite. In: Carcano G, Dionigi R Eds. Le ferite. Elsevier Masson Italia 1998;33-39

Dominioni L, Bianchi V, Chiappa A, Ochetti A. Polmoni. In: Dionigi R Ed. Chirurgia, 2nd edition. Elsevier Masson Italia 1997;648-674

Dominioni L, Alberio MG, Bianchi V. Pleura. In: Dionigi R Ed. Chirurgia, 2nd edition. Elsevier Masson Italia 1997;616-627

Dominioni L, Ochetti A, Bianchi V. Parete toracica. In: Dionigi R Ed. Chirurgia, 2nd edition. Elsevier Masson Italia 1997;609-615

Gaeta L, Benevento A, Chiappa A, Carcano G, Barbera D, Bianchi V, Dionigi R. Trattamento chirurgico del carcinoma dell’ano. In: Natale C, Galeazzi R, Battelli T Eds. I tumori intestinali. AM Edizioni 1997;213-222

Dominioni L, Berizzi F, Dozio E, Imperatori A, Bianchi V, Dionigi R. Fisiopatologia della nutrizione enterale postoperatoria immediata (NEPI). In: Bogen M, Malacrida R, Martinoli S Eds. L’alimentazione artificiale tra desideri biologici e limitazione della natura. Alice 1996;61-66

Dominioni L, Bianchi V, Imperatori A, Dionigi R. Use of intravenous immunoglobulin in patients at high risk of bacterial infections. In: Kazatchkine MD, Morell A Eds. Intravenous Immunoglobulin Research and Therapy, New York: the Partenon Publishing Group Ltd. 1996;209-213

Dominioni L, Bianchi V, Imperatori A, Minoia G, Dionigi R. Completed clinical trials of high-dose polyvalent IgG (Sandoglobulin®) in surgical infections. In: Faist E, Baue AE, Schildberg FW Eds. The immune consequences of trauma, shock and sepsis – Mechanisms and therapeutic approaches. MOF, MODS and SIRS – Concepts, clinical correlates and therapy. Pabst Science Publishers, 1996. Vol. 2/2, pp.1078-83

Dominioni L, Chiappa A, Peloni G, Bianchi V. Sepsi batterica e micotica in chirurgia. In: Proceedings 97° Congresso Società Italiana di Chirurgia. Trieste, October 8-11, 1995. Pozzi ed., Vol. 2°, pp. 247-57

Dionigi R, Dominioni L, Benevento A, Carcano G, Imperatori A, Bianchi V. Use of staplers and of early post-operative enteral feeding for pancreatic resections. In: Proceedings of the Italian Chapter American College of Surgeons, 1995, pp. 93-100

Dominioni L, Bianchi V, Imperatori A. Severely septic surgical patients. In: Kazatchkine MD Ed. Intravenous Immunoglobulin Therapy. Clinical benefits and future prospects. The Partenon Publishing Group Ltd., New York, 1995; pp. 85-88

Altre pubblicazioni:

Bianchi Galdi V. “Che cosa ti preparo?” – Suggerimenti pratici online per affrontare la difficoltà di alimentazione nel paziente oncologico. Palliative-ch 2012;3:26-30

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A, and the QC3 Working Group. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino. A population-based study. Schweizer Krebsbulletin 2012;3:205-8

Bianchi Galdi V. Burnout e resilienza. Palliative-ch 2011:4:5-11

Bianchi Galdi V, Spitale A, Bordoni A. Indicatori di qualità nelle cure oncologiche: studio QC3. Tribuna Medica Ticinese 2011; 76(1): 51-55

 

Editoriali:

Bianchi Galdi V, Gamondi C. Editoriale. Palliative-ch 2012;3:4

Bianchi Galdi V, Gamondi C. Editoriale. Palliative-ch 2011:4:4

Bianchi Galdi V, Gamondi C. Editoriale. Palliative-ch 2010;2:4

 

Edited journals:

Bianchi Galdi V, Gamondi C. Palliative-ch “Alimentazione nelle cure palliative”. 2012;3:4

Bianchi Galdi V, Gamondi C. Palliative-ch “Caring for the Carers. Burnout”. 2011:4:1-61

Bianchi Galdi V, Gamondi C. Palliative-ch “Malattie croniche”. 2010;2:1-80

2001: “Fondazione per la ricerca sulla trasfusione e sui trapianti” Research Grant, Lugano (CH)

1996: Premio di Laurea I.N.P.D.A.I., Roma (I)

1994: European Society for Organ Transplantation (E.S.O.T. - SANDOZ) Fellowship

2011 - 2013. Collaboratrice Scientifica e Coordinatrice di Progetto, presso il Registro Cantonale dei Tumori (Direttore: Dr. med. A. Bordoni), Istituto Cantonale di Patologia, Locarno.
Progetto: “Indicators of Quality of Cancer Care (QC3) in Southern Switzerland”. 
Lo studio è stato sponsorizzato da: Krebsforschung Schweiz, grant no. KFS-02668-08-2010; ABREOC (Advisory Board Ente Ospedaliero Bellinzona), grant no. ABREOC 10/2010, Swiss Academy of Medical Sciences, grant no. KZS 3/11; Zonta Club Locarno.

2001 - 2002. Ricercatrice presso l’Inselspital Bern, Dipartimento di Ematologia, Laboratorio di Ematologia Sperimentale (Direttore: Prof. Dr. med. B. Lämmle), Berna.
Progetti svolti: 
-    “Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies”
-    “Von Willebrand factor-cleaving protease in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura (TTP)”
-    “Von Willebrand factor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock”
Gli studi sono stati in parte sponsorizzati da un grant della “Fondazione per la ricerca sulla trasfusione e sui trapianti”, Lugano.

1999 - 2000. Ricercatrice presso l’ETH-Zentrum-Swiss Federal Institute of Technology, Dipartimento di Biochimica (Responsabile: H. Lutz, Ph.D.), Zurigo.
Progetto: “Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level”. 
Lo studio è stato sponsorizzato da: KTI grants no. 3189.1 and 3772.1 of ZLB Central Laboratory, Blood Transfusion Services of the Swiss Red Cross, Bern, and by the Swiss Government.

1997 - 1998. Ricercatrice presso il Dipartimento di BioTecnologie (DIBIT), Unità di Immunochimica (Responsabile: Dr. med. Paolo Dellabona e Giulia Casorati, Ph.D.), Ospedale San Raffaele, Milano.
Progetto: “Characterization of new chemokines mPBP-like, mPF4-like e hIP10-like in tumoral angiogenesis”.

1995 - 1997. Laboratorio di Chirurgia Sperimentale dell’Università di Pavia, Sede di Varese (I) (Direttore: Prof. Dr. med. R. Dionigi).
Progetti svolti: 
-   “In vitro effect of intravenous immunoglobulins (IVIG) on the opsonophagocytic function of neutrophils from severely septic patients”
-   “Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins”
-   “Immediate postoperative enteral nutrition, sequential treatment of infected pancreatic necrosis with zipper abdominal re-explorations, open abdomen and continuous lavage”
 

1994. Visiting Student (E.S.O.T. Fellowship) presso la Ludwig-Maximilians-Universität, Klinikum Großhadern, Institute of Surgical Research (Director: Prof. Dr. med. Dr. med. vet. C. Hammer).
Progetto: “Cytological monitoring of heart and liver transplant patients”.

Bianchi Galdi V. Bronze für’s Tessin – Erfolgsgeschichten des Ospedale Regionale di Lugano. Atti 8. Nikotintagung Vergangenheit und Zukunft, 24 settembre 2020, Aarau (CH) (oral presentation)

Majno P, Balzarotti R, Vitali G, Fournier I, Andres A, Bianchi V, Cristaudi A, Rosso R, Morel P, Rubbia-Brandt L, Toso C. Evaluating the quality of liver resection for colorectal liver metastases using a standardised definition of the difficulty to obtain R0 surgical margins. Proceedings European Surgical Association, 24th Annual Meeting. Bucharest, 4-6 maggio 2017 (oral presentation)

Bianchi Galdi V, Balzarotti R, De Giorgi A, Majno P, Rosso R. Valutazione della qualità e degli Outcome Quality Standards nella chirurgia pancreatica all’UCEP. Proceedings 6^ Giornata Della Ricerca Clinica della Svizzera Italiana. Lugano, 18.03.2016 (oral presentation)

Bianchi Galdi V, Balzarotti R, Bihl F, Maffei M, Alerci M, Saletti P, Montemurro M, Majno P. UCEP (Unità Cantonale oncologica, radiologica e chirurgica Epatobilio-Pancreatica): un esempio di collaborazione intra- ed inter-cantonale. Proceedings EOC Congress. Lugano, Switzerland, April 2, 2015 (oral presentation)

Bianchi Galdi V, Franzetti-Pellanda A, Spitale A, Valli MC, Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A. Quality indicators in radiation therapy for rectal cancer. A population-based study in Southern Switzerland. Proceedings 2nd ESTRO Forum. Geneva, Switzerland, April 19-23, 2013. Radiotherapy & Oncology 2013;106:S162 (oral presentation)

Ortelli L, Bianchi Galdi V, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A, Spitale A and the QC3 Colorectal Working group. Indicatori di qualità delle cure per I tumori colo-rettali: risultati e valutazioni per il Ticino dal 2011 al 2012. Terza giornata della Ricerca Clinica della Svizzera Italiana. Lugano, Switzerland, March 22, 2013 (oral presentation)

Bianchi V, Spitale A, Mazzucchelli L, Bordoni A. Quality indicators of clinical cancer care (QC3) in the territory of Canton Ticino: preliminary results in colorectal cancer. Proceedings 78th Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, November 8-10, 2012. Der Pathologe 2012;33:572 (poster)

Bordoni A, Bianchi Galdi V, Mazzucchelli L, Spitale A and the QC3 CRC Working Group. Population-based quality indicators of cancer care: the QC3 pilot study on colorectal cancer patients. SAKK Symposium. Bern, Switzerland, November 1, 2012 (oral presentation)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. Defining evidence-based clinical oncologic cares quality indicators. Proceedings ENCR 2012 Scientific Meeting. Cork, Ireland, September 19-20, 2012 (poster)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. QC3: quality of comprehensive cancer care in Southern Switzerland. Proceedings 34th International Association of Cancer Registries (IARC) Conference. Cork, Ireland, September 17-19, 2012 (poster)

Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. Qualità delle cure contro il cancro (QC3) nel territorio della Svizzera Italiana. Risultati preliminari dei tumori colo-rettali incidenti nel 2011. Proceedings XXXVII GRELL Congress. Porto, Portugal, May 16-18, 2012 (poster)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Mazzola P, Peverelli S, Bordoni A and the QC3 Working Group. QC3: qualità delle cure contro il cancro in Canton Ticino. Seconda Giornata della Ricerca Clinica della Svizzera Italiana. Bellinzona, Switzerland, March 23, 2012 (poster)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. Proceedings 77th Annual Meeting of the Swiss Society of Pathology. Luzern, Switzerland, November 10-12, 2011. Der Pathologe 2011;32:536-7 (poster)

Bordoni A, Bianchi Galdi V, Mazzucchelli L, Spitale A. QoCC study: indicators of quality of cancer care in Southern Switzerland. Proceedings 33rd International Association of Cancer Registries (IARC) Conference. Balaclava, Mauritius, October 11-13, 2011 (poster)

Bianchi Galdi V, Spitale A, Bordoni A and the QC3 Working Group. QC3 Pilot study: Qualità delle Cure nella lotta Contro il Cancro. SAKK summer semi-annual meeting. Bern, Switzerland, June 23, 2011 (oral presentation)

Bordoni A, Bianchi Galdi V, Spitale A, Mazzucchelli L and the QC3 Working Group. Population-based quality indicators of cancer care: the QC3 pilot study. SAKK summer semi-annual meeting. Bern, Switzerland, June 23, 2011 (oral presentation)

Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. XXXVI GRELL Congress. Caen, France, June 1-3, 2011 (poster)

Bianchi V, Celio D, Oudineche A, Mazzucchelli L, Saletti P, Rosso R. Bizarre cell leiomyoma of the duodenum: an entity of peculiar interest. Proceedings 96e Congrès Annuel de la Société Suisse de Chirurgie. Montreaux, Switzerland, June 10-12, 2009. Swiss Knife 2009; special edition: 68.60 (poster)

Lutz HU, Stammler P, Bianchi V, Trüeb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ. Intravenously applied IgG stimulates complement attenuation in dermatomyositis at the amplifying C3 convertase level. Proceedings American Academy of Allergy, Asthma and Immunology (AAAAI) 60th Anniversary MeetingJ. Denver, Colorado, USA, March 7-12, 2003. J Allerg Clin Immunol 2003;111(1):S316 (oral presentation)

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for TTP. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S (oral presentation

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Procedings 70e Assemblée Annuelle de la Société Suisse de Médecine Interne. Genève, Switzerland, April 25-27 2002. Forum Med Suisse 2002; 2(10): 31S (oral presentation)

Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B. Specificity of severe von Willebrand factor-cleaving protease deficiency for thrombotic thrombocytopenic purpura. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1): A6 (oral presentation

Bianchi V, Zeerleder S, Kessler P, Robles R, Wuillemin W, Alberio L, Lämmle B. vWF-cleaving protease in severe sepsis and septic shock. Proceedings 46. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung. Erfurt, Germany, February 20-23, 2002. Ann Hematol 2002; 81(S1):A6 (oral presentation)

Bianchi V, Kessler Ph, Zeerleder S, Alberio L and Lämmle B. von Willebrand factor (vWF) and von Willebrand factor-cleaving protease (vWF-cp) activity in severe sepsis and septic shock. Proceedings of the 7th Cardiovascular Biology and Clinical Implications Meeting. Interlaken, Switzerland, October 26-27, 2001 (poster)

Dominioni L, Chiappa A, Bianchi V and Dionigi R. Sequential treatment of infected pancreatic necrosis with zipper abdominal re-explorations, open abdomen and continuous lavage. Proceedings 10th Meeting of the Association of Academic Departments of Surgery in Europe (ADSE). Sigriswil, Bern, Switzerland, April 19-20, 1996 (oral presentation)

Dominioni L, Bianchi V, Imperatori A and Dionigi R. In vitro effect of three generations of intravenous immunoglobulins on the opsonophagocytic function of neutrophils from severely septic patients. Proceedings Interlaken’s Fourth Symposium on IVIG. Interlaken, Switzerland, June 11-13, 1996 (oral presentation)

Imperatori A, Dominioni L, Bianchi V, Benevento A, Dionigi R. Uso delle IgG polivalenti ad alte dosi nella terapia dei pazienti chirurgici gravemente settici. Proceedings 97° Congresso Società Italiana di Chirurgia. Trieste, Italy, October 8-11, 1995 (oral presentation)

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Survival of septic patients as related to their sepsis score and to the therapeutic use of high-dose immunoglobulins. Proceedings “8th Meeting of Academic Departments of Surgery in Europe (ADSE)”. Castellfedels, Barcelona, Spain, March 25-26, 1994 (oral presentation)

Dominioni L, Gennari R, Minoia G, Imperatori A, Bianchi V, Dionigi R. Sopravvivenza dei pazienti settici correlata al sepsis score iniziale e alla terapia con IgG polivalenti ad alte dosi. Proceedings XVIII Congresso Società Italiana di Ricerche in Chirurgia. Grado, Italy, September 1994 (oral presentation)
 

10.09.2021
Consulenze mediche Radio 3i - Dr.ssa Valentina Bianchi Galdi
Consulenze mediche su Radio 3i Dr.ssa Valentina Bianchi Galdi

Portrait Dr. med. Valentina Bianchi Galdi

Sprachen

Italiano, Inglese

Kontakt

Ars Medica Centro dello Sport c/o Centro Ambrosart
Via Cantonale 38
6828 Manno

T +41 91 611 64 80 F +41 91 611 64 90 vbianchigaldi@arsmedica.ch

Download vCard